Ellen Matzkin

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis

Pierre D. Delmas, Michael R. McClung, José Zanchetta et al. · Bone · 2007 · 97 citations

Bone Disease, Bone Health, Medicine +6

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double‐blind, placebo‐controlled, randomized, proof‐of‐concept study

Clarissa E. Vergunst, Daniëlle M. Gerlag, Lisa Von Moltke et al. · Arthritis & Rheumatism · 2009 · 79 citations

Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results

Pierre D. Delmas, C.L. Benhamou, Z. Man et al. · Osteoporosis International · 2007 · 68 citations

Therapeutic Drug Monitoring, Consecutive Days, Pharmacology +5

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data

Michael R. McClung, José Zanchetta, Artur Racewicz et al. · Osteoporosis International · 2012 · 31 citations · Full text

Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study

Louis‐Georges Ste‐Marie, Jacques P. Brown, John F. Beary et al. · Clinical Therapeutics · 2009 · 21 citations

Bone Disease, Bone Health, Medicine +8